Sorry, you need to enable JavaScript to visit this website.

Study Comparing Levels of Adalimumab in the Blood After Multiple Switches Between Humira® and Abrilada™ (PF-06410293) With Humira® Alone in Patients With Rheumatoid Arthritis

Study Comparing Levels of Adalimumab in the Blood After Multiple Switches Between Humira® and Abrilada™ (PF-06410293) With Humira® Alone in Patients With Rheumatoid Arthritis. A Randomized Comparative Study Assessing the Switching Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis.

Category & Conditions: Immune System Diseases and Conditions
Medicine: abrilada (PF-06410293)
ClinicalTrials.gov Identifier (NCT): NCT04230213
Protocol ID: B5381012
    Share
PrintDownload
Open Plain Language Summary Result: Click here